{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:01:57Z","timestamp":1770912117896,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20180625"],"award-info":[{"award-number":["BK20180625"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2103100"],"award-info":[{"award-number":["2021YFC2103100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22008090"],"award-info":[{"award-number":["22008090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.actbio.2025.02.057","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T19:23:22Z","timestamp":1740684202000},"page":"436-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["DNA nanovaccines derived from ferritin-modified glycogens for targeted delivery to immature dendritic cells and for promotion of Th1 cell differentiation"],"prefix":"10.1016","volume":"196","author":[{"given":"Jun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2479-7555","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.actbio.2025.02.057_bib0001","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"issue":"23","key":"10.1016\/j.actbio.2025.02.057_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168297","article-title":"DNA vaccines: history, molecular mechanisms and future perspectives","volume":"435","author":"Pagliari","year":"2023","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.actbio.2025.02.057_bib0003","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.drudis.2019.12.003","article-title":"Comparison of DNA and mRNA vaccines against cancer","volume":"25","author":"Jahanafrooz","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.actbio.2025.02.057_bib0004","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4161\/21645515.2014.980686","article-title":"DNA vaccine for cancer immunotherapy","volume":"10","author":"Yang","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.actbio.2025.02.057_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pharmthera.2017.02.016","article-title":"DNA vaccines for prostate cancer","volume":"174","author":"Zahm","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13046-019-1154-7","article-title":"Cancer DNA vaccines: current preclinical and clinical developments and future perspectives","volume":"38","author":"Lopes","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.actbio.2025.02.057_bib0007","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.actbio.2025.02.057_bib0008","series-title":"Novel Gene Ther. Approaches","first-page":"Ch. 10","article-title":"Challenges in advancing the field of cancer gene therapy: an overview of the multi-functional nanocarriers","author":"Azam","year":"2013"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0009","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/vaccines12010071","article-title":"DNA vaccines: their formulations, engineering and delivery","volume":"12","author":"Kozak","year":"2024","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.057_bib0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/17425247.2016.1121990","article-title":"Clinical potential of electroporation for gene therapy and DNA vaccine delivery","volume":"13","author":"Lambricht","year":"2016","journal-title":"Expert Opin. Drug Delivery"},{"issue":"6","key":"10.1016\/j.actbio.2025.02.057_bib0011","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/156652311798192860","article-title":"Plasmid DNA gene therapy by electroporation: principles and recent advances","volume":"11","author":"Murakami","year":"2011","journal-title":"Curr. Gene Ther."},{"issue":"2","key":"10.1016\/j.actbio.2025.02.057_bib0012","article-title":"Improved DNA vaccine delivery with needle-free injection systems","volume":"11","author":"Ledesma-Feliciano","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0013","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"npj Vaccines"},{"issue":"6","key":"10.1016\/j.actbio.2025.02.057_bib0014","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.actbio.2025.02.057_bib0015","first-page":"307","article-title":"Gene-based vaccine approaches for respiratory syncytial virus","volume":"372","author":"Loomis","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.actbio.2025.02.057_bib0016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1749-6632.1995.tb44735.x","article-title":"Adenovirus and adeno-associated virus as vectors for gene therapy","volume":"772","author":"Berns","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0017","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s10194-021-01324-5","article-title":"Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis","volume":"22","author":"Garc\u00eda-Azor\u00edn","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.actbio.2025.02.057_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.782335","article-title":"Potential anionic substances binding to platelet factor 4 in vaccine-induced thrombotic thrombocytopenia of ChAdOx1-S vaccine for SARS-CoV-2","volume":"12","author":"Pang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2025.02.057_bib0019","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/vaccines12060666","article-title":"Lipid nanoparticles outperform electroporation in delivering therapeutic HPV DNA vaccines","volume":"12","author":"Li","year":"2024","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.057_bib0020","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1021\/acsami.3c14714","article-title":"Development of polymer\u2013Lipid hybrid nanoparticles for large-sized plasmid DNA transfection","volume":"16","author":"Maeki","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.actbio.2025.02.057_bib0021","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1021\/acs.molpharmaceut.9b01262","article-title":"Vitamin E scaffolds of pH-responsive lipid nanoparticles as DNA vaccines in cancer and protozoan infection","volume":"17","author":"Maeta","year":"2020","journal-title":"Mol. Pharmaceutic."},{"issue":"7","key":"10.1016\/j.actbio.2025.02.057_bib0022","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1158\/1535-7163.MCT-05-0540","article-title":"Mannosylated chitosan nanoparticle\u2013based cytokine gene therapy suppressed cancer growth in BALB\/c mice bearing CT-26 carcinoma cells","volume":"5","author":"Kim","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"31","key":"10.1016\/j.actbio.2025.02.057_bib0023","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1016\/j.biomaterials.2007.07.002","article-title":"Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly","volume":"28","author":"Zhou","year":"2007","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.actbio.2025.02.057_bib0024","first-page":"1238","article-title":"Gene therapy based on interleukin-12 loaded chitosan nanoparticles in a mouse model of fibrosarcoma","volume":"19","author":"Soofiyani","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.actbio.2025.02.057_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109229","article-title":"PLGA cationic nanoparticles, obtained from nano-emulsion templating, as potential DNA vaccines","volume":"120","author":"Soler Besumbes","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.actbio.2025.02.057_bib0026","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rvsc.2021.02.010","article-title":"Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants","volume":"136","author":"Yang","year":"2021","journal-title":"Res. Vet. Sci."},{"issue":"18","key":"10.1016\/j.actbio.2025.02.057_bib0027","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.biomaterials.2008.03.011","article-title":"Enhancement of poly(orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine)","volume":"29","author":"Nguyen","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.02.057_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123959","article-title":"Mannosylated polyethylenimine-cholesterol-based nanoparticles for targeted delivery of minicircle DNA vaccine against COVID-19 to antigen-presenting cells","volume":"654","author":"Eus\u00e9bio","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.actbio.2025.02.057_bib0029","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/acsbiomaterials.6b00418","article-title":"Polymers for DNA vaccine delivery","volume":"3","author":"Zhang","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.actbio.2025.02.057_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121303","article-title":"Dendrimers in vaccine delivery: recent progress and advances","volume":"280","author":"Chowdhury","year":"2022","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2025.02.057_bib0031","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/pharmaceutics15041106","article-title":"Dendrimer-mediated delivery of DNA and RNA vaccines","volume":"15","author":"Kisakova","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2025.02.057_bib0032","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.2147\/IJN.S139126","article-title":"Induction of a robust immune response against avian influenza virus following transdermal inoculation with H5-DNA vaccine formulated in modified dendrimer-based delivery system in mouse model","volume":"12","author":"Bahadoran","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0033","doi-asserted-by":"crossref","first-page":"e86578","DOI":"10.1371\/journal.pone.0086578","article-title":"PAMAM-lys, a novel vaccine delivery vector, enhances the protective effects of the SjC23 DNA vaccine against Schistosoma japonicum infection","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.actbio.2025.02.057_bib0034","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/biom9080330","article-title":"Cytotoxicity of dendrimers","volume":"9","author":"Janaszewska","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.actbio.2025.02.057_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2017.08.009","article-title":"Lymph node targeting strategies to improve vaccination efficacy","volume":"267","author":"Jiang","year":"2017","journal-title":"J. Controll. Rel."},{"issue":"10","key":"10.1016\/j.actbio.2025.02.057_bib0036","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/acs.accounts.0c00260","article-title":"Engineering strategies for lymph node targeted immune activation","volume":"53","author":"Chen","year":"2020","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0037","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Controll. Rel."},{"issue":"10","key":"10.1016\/j.actbio.2025.02.057_bib0038","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri2173","article-title":"Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting","volume":"7","author":"Tacken","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2025.02.057_bib0039","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jmr.650","article-title":"Targeting dendritic cells for priming cellular immune responses","volume":"16","author":"Gogolak","year":"2003","journal-title":"J. Mol. Recognit."},{"issue":"3","key":"10.1016\/j.actbio.2025.02.057_bib0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.151.3.673","article-title":"The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments","volume":"151","author":"Mahnke","year":"2000","journal-title":"J. Cell Biol."},{"issue":"37","key":"10.1016\/j.actbio.2025.02.057_bib0041","doi-asserted-by":"crossref","first-page":"25826","DOI":"10.1021\/acsnano.4c09053","article-title":"Glucosylated nanovaccines for dendritic cell-targeted antigen delivery and amplified cancer immunotherapy","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.actbio.2025.02.057_bib0042","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2567.2006.02512.x","article-title":"Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205\u2013DCL-1 fusion protein upon dendritic cell maturation","volume":"120","author":"Butler","year":"2007","journal-title":"Immunology"},{"issue":"46","key":"10.1016\/j.actbio.2025.02.057_bib0043","doi-asserted-by":"crossref","first-page":"15727","DOI":"10.1074\/jbc.RA120.014690","article-title":"Interactions of ferritin with scavenger receptor class A members","volume":"295","author":"Yu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.actbio.2025.02.057_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106974","article-title":"L-ferritin binding to scara5: a new iron traffic pathway potentially implicated in retinopathy","volume":"9","author":"Mendes-Jorge","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.actbio.2025.02.057_bib0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1242\/jcs.022418","article-title":"Distribution and lateral mobility of DC-SIGN on immature dendritic cells\u2013implications for pathogen uptake","volume":"121","author":"Neumann","year":"2008","journal-title":"J. Cell Sci."},{"issue":"18","key":"10.1016\/j.actbio.2025.02.057_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904625","article-title":"Glycogen as a building block for advanced biological materials","volume":"32","author":"Besford","year":"2020","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.actbio.2025.02.057_bib0047","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.actbio.2025.02.057_bib0048","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/pharmaceutics15071884","article-title":"Aluminum adjuvants-'back to the future","volume":"15","author":"Laera","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.actbio.2025.02.057_bib0049","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/erv.11.192","article-title":"Development and evaluation of AS03, an adjuvant system containing \u03b1-tocopherol and squalene in an oil-in-water emulsion","volume":"11","author":"Gar\u00e7on","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actbio.2025.02.057_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5","key":"10.1016\/j.actbio.2025.02.057_bib0051","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s40005-023-00633-y","article-title":"Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy","volume":"53","author":"Li","year":"2023","journal-title":"J. Pharm. Invest."},{"issue":"3","key":"10.1016\/j.actbio.2025.02.057_bib0052","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12250-013-3291-z","article-title":"Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity","volume":"28","author":"Naderi","year":"2013","journal-title":"Virol. Sin."},{"key":"10.1016\/j.actbio.2025.02.057_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130660","article-title":"pGM-CSF as an adjuvant in DNA vaccination against SARS-CoV-2","volume":"264","author":"Liu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.actbio.2025.02.057_bib0054","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mt.2010.268","article-title":"DAI (DLM-1\/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity","volume":"19","author":"Lladser","year":"2011","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.actbio.2025.02.057_bib0055","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00262-022-03144-1","article-title":"Interleukin-12 as an in situ cancer vaccine component: a review","volume":"71","author":"Cheng","year":"2022","journal-title":"Cancer Immunol., Immunother"},{"issue":"8","key":"10.1016\/j.actbio.2025.02.057_bib0056","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2174\/1568009617666170427102729","article-title":"Impact of IL-12 in cancer","volume":"17","author":"Lu","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0057","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.actbio.2025.02.057_bib0058","first-page":"419","article-title":"An efficient nonviral gene-delivery vector based on hyperbranched cationic glycogen derivatives","volume":"9","author":"Liang","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.actbio.2025.02.057_bib0059","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3390\/ijms24032914","article-title":"Optimization of the hemolysis assay for the assessment of cytotoxicity","volume":"24","author":"S\u00e6b\u00f8","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"43","key":"10.1016\/j.actbio.2025.02.057_bib0060","doi-asserted-by":"crossref","DOI":"10.1039\/C8TB00967H","article-title":"The great escape: how cationic polyplexes overcome the endosomal barrier","volume":"6","author":"Bus","year":"2018","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.actbio.2025.02.057_bib0061","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12274-019-2301-3","article-title":"Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration","volume":"12","author":"Howard","year":"2019","journal-title":"Nano Res"},{"key":"10.1016\/j.actbio.2025.02.057_bib0062","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","article-title":"Polyethylenimine (PEI) in gene therapy: current status and clinical applications","volume":"362","author":"Casper","year":"2023","journal-title":"J. Controll. Rel."},{"issue":"23","key":"10.1016\/j.actbio.2025.02.057_bib0063","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.3390\/cancers13235889","article-title":"Immunotherapy approaches in HPV-associated head and neck cancer","volume":"13","author":"Julian","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.057_bib0064","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.actbio.2025.02.057_bib0065","article-title":"CD3+CD4-CD8- (Double-Negative) T cells in inflammation, immune disorders and cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2025.02.057_bib0066","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/imm.13441","article-title":"Double-negative T cells: setting the stage for disease control or progression","volume":"165","author":"Velikkakam","year":"2022","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.057_bib0067","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.167.1.221","article-title":"Positive regulatory role of IL-12 in macrophages and modulation by IFN-\u03b31","volume":"167","author":"Grohmann","year":"2001","journal-title":"J. Immunol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:59:17Z","timestamp":1762556357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":67,"alternative-id":["S1742706125001539"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.02.057","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA nanovaccines derived from ferritin-modified glycogens for targeted delivery to immature dendritic cells and for promotion of Th1 cell differentiation","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.02.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}